AR030625A1 - Derivados de cromanona - Google Patents

Derivados de cromanona

Info

Publication number
AR030625A1
AR030625A1 ARP010104249A ARP010104249A AR030625A1 AR 030625 A1 AR030625 A1 AR 030625A1 AR P010104249 A ARP010104249 A AR P010104249A AR P010104249 A ARP010104249 A AR P010104249A AR 030625 A1 AR030625 A1 AR 030625A1
Authority
AR
Argentina
Prior art keywords
hal
chromanone derivatives
ocf3
chromanone
derivatives
Prior art date
Application number
ARP010104249A
Other languages
English (en)
Inventor
Bokel Heinz-Hermann Dr
Muermann Christoph Dr
Schmid Uschi Dr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR030625A1 publication Critical patent/AR030625A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Derivados de cromanona de formula 1, donde R1 a R4 son cada uno, independientemente entre sí, H, A, CN, Hal, OR5, COOR5, CF3, OCF3, NO2, Ar, OAr, N(R5)2 o CON(R5)2, R5 es H o A, A es alquilo que posee de 1 a 6 átomos de carbono, Ar es fenilo no sustituido o sustituido por A, OR5, CN, Hal, CF3, OCF3, NO2 o N(R5)2, Hal es F, Cl, Br o I, y las sales de los mismos, que son adecuados como intermediarios para la síntesis de medicamentos.
ARP010104249A 2000-09-07 2001-09-07 Derivados de cromanona AR030625A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10044091A DE10044091A1 (de) 2000-09-07 2000-09-07 Chromanonderivate

Publications (1)

Publication Number Publication Date
AR030625A1 true AR030625A1 (es) 2003-08-27

Family

ID=7655302

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104249A AR030625A1 (es) 2000-09-07 2001-09-07 Derivados de cromanona

Country Status (19)

Country Link
US (1) US6812353B2 (es)
EP (1) EP1317438A1 (es)
JP (1) JP2004508363A (es)
KR (1) KR20030040402A (es)
CN (1) CN1249044C (es)
AR (1) AR030625A1 (es)
AU (1) AU2001284039A1 (es)
BR (1) BR0113584A (es)
CA (1) CA2421287A1 (es)
DE (1) DE10044091A1 (es)
HU (1) HUP0302065A3 (es)
MY (1) MY133893A (es)
NO (1) NO20031034D0 (es)
PL (1) PL362761A1 (es)
RU (1) RU2273638C2 (es)
SK (1) SK3332003A3 (es)
UA (1) UA75892C2 (es)
WO (1) WO2002020507A1 (es)
ZA (1) ZA200302632B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10044091A1 (de) 2000-09-07 2002-04-04 Merck Patent Gmbh Chromanonderivate
CN1561337A (zh) 2001-10-05 2005-01-05 惠氏公司 2-基苯并二氢吡喃衍生物的立体有择合成方法
WO2003031429A1 (en) 2001-10-05 2003-04-17 Wyeth A process for the stereoselective synthesis of 2-hydroxymethyl-chromans
US7435837B2 (en) * 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US20050261347A1 (en) * 2003-10-24 2005-11-24 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
WO2006116165A1 (en) * 2005-04-22 2006-11-02 Wyeth Chromane and chromene derivatives and uses thereof
US7528267B2 (en) 2005-08-01 2009-05-05 Girindus America, Inc. Method for enantioselective hydrogenation of chromenes
CA2628173A1 (en) 2005-11-03 2007-05-10 F. Hoffmann-La Roche Ag Arylsulfonylchromans as 5-ht6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors
RU2468018C1 (ru) * 2011-10-06 2012-11-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский университет дружбы народов" (РУДН) Способ получения производных 4-оксо-4h-хроменов, содержащих винильную и енаминную группировки
HUE034661T2 (en) * 2013-07-18 2018-02-28 Toyama Chemical Co Ltd A therapeutic agent for diseases based on the inhibitory effect of macrophage migration inhibition factor
WO2015106789A1 (de) * 2014-01-17 2015-07-23 Merck Patent Gmbh Materialien f?r organische elektrolumineszenzvorrichtungen
WO2019212211A1 (en) * 2018-04-30 2019-11-07 Gachon University Of Industry-Academic Cooperation Foundation Antiangiogenic chromane derivative and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2611910A1 (de) 1976-03-20 1977-09-22 Bayer Ag Chromanone-(4)
CH619701A5 (es) 1975-08-07 1980-10-15 Bayer Ag
SI0707007T1 (en) * 1994-10-14 2002-04-30 Merck Patent Gmbh (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
DE19858341A1 (de) 1998-12-17 2000-06-21 Merck Patent Gmbh Chromanderivate
DE10044091A1 (de) 2000-09-07 2002-04-04 Merck Patent Gmbh Chromanonderivate

Also Published As

Publication number Publication date
ZA200302632B (en) 2004-09-02
RU2273638C2 (ru) 2006-04-10
DE10044091A1 (de) 2002-04-04
KR20030040402A (ko) 2003-05-22
HUP0302065A3 (en) 2005-07-28
CN1451001A (zh) 2003-10-22
MY133893A (en) 2007-11-30
SK3332003A3 (en) 2003-07-01
PL362761A1 (en) 2004-11-02
HUP0302065A2 (hu) 2003-09-29
BR0113584A (pt) 2003-07-15
EP1317438A1 (de) 2003-06-11
CN1249044C (zh) 2006-04-05
CA2421287A1 (en) 2003-03-05
US6812353B2 (en) 2004-11-02
WO2002020507A1 (de) 2002-03-14
UA75892C2 (en) 2006-06-15
JP2004508363A (ja) 2004-03-18
US20040092579A1 (en) 2004-05-13
NO20031034L (no) 2003-03-06
NO20031034D0 (no) 2003-03-06
AU2001284039A1 (en) 2002-03-22

Similar Documents

Publication Publication Date Title
AR030625A1 (es) Derivados de cromanona
AR028914A1 (es) 2-guanidino-4-aril-quinazolinas como inhibidores de nhe-3
AR049401A1 (es) Aza-biciclononanos
BRPI0407501A (pt) glicolipìdeos e método sintético dos mesmos bem como seus intermediários sintéticos, e método sintético dos mesmos
CY1110355T1 (el) Ενεργοποιητης του ενεργοποιουμενου απο πολλαπλασιαστη υπεροξυσωματων υποδοχεα δ
AR049291A1 (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
ES2188016T3 (es) Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas.
CO5560542A2 (es) Derivados de 1,6-naftiridina y su uso para el tratamiento de la diabetes y transtornos relacionados
AR047456A1 (es) Derivados de amidas, procesos para su preparacion y uso como insecticidas
AR035371A1 (es) Aminotiazoles, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de un medicamento
PT96890A (pt) Processo para a preparacao de novos derivados com estrutura naftalenica e de composicoes farmaceuticas que os contem
HRP20090101T3 (en) N-(1h-indolyl)-h-indole-2-carboxamide derivatives, their preparation and their therapeutic use
CO5160347A1 (es) Derivados de acido carbamico
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
ES2213007T3 (es) Derivados de 4,5-diaril-3(2h)-furanona como inhibidores de la ciclooxigenasa-2.
NO975294D0 (no) Diaryldiaminderivater og deres anvendelse som delta-opioid (ant)-agonister
AR026351A1 (es) Derivados de pirrol como inhibidores de la fosfodiesterasa vii
ES2253568T3 (es) Compuestos heterociclicos para el uso en el tratamiento de los trastornos de las vias urinarias.
AR054583A1 (es) Pantoprazol isotopicamente sustituido
DE602004015331D1 (de) Verfahren für fluorcytidinderivate
BR0208812A (pt) Derivados fenil heterociclil éter como inibidores de recaptação de serotonina
AR037821A1 (es) 2-guanidin-4-heterociclilquinazolinas
AR021900A1 (es) Derivados del cromano, sus sales y enantiomeros, un procedimiento para su preparacion y el empleo de los mismos como productos intermedios para la sintesis de medicamentos.
MX9306257A (es) Compuestos fotocromicos, su preparacion y su uso.
AR044320A1 (es) Derivados 3-decladinosilo de la clase de 9a - n-carbamoil - y 9a-ntiocarbamoil- 9 dihidro-9a aza- 9a - homoeritromicina a

Legal Events

Date Code Title Description
FA Abandonment or withdrawal